Biodegradable Implant for Tissue Repair After Glaucoma Drainage Device Surgery

@article{Rosentreter2012BiodegradableIF,
  title={Biodegradable Implant for Tissue Repair After Glaucoma Drainage Device Surgery},
  author={A. Rosentreter and A. Schild and S. Dinslage and T. Dietlein},
  journal={Journal of Glaucoma},
  year={2012},
  volume={21},
  pages={76–78}
}
  • A. Rosentreter, A. Schild, +1 author T. Dietlein
  • Published 2012
  • Medicine
  • Journal of Glaucoma
  • Aim/BackgroundTo report a novel technique using biodegradable material to cover exposed glaucoma tube shunts. MethodsA case report of a single patient who underwent drainage tube shunt surgery with the Baerveldt drainage device for intractable glaucoma. Four months post operation the tube became exposed through necrosis of the overlying scleral flap and conjunctiva. The defect was repaired by fixation of the tube to the sclera, with a slice of an ologen implant as a patch, covered by the… CONTINUE READING
    23 Citations

    Topics from this paper.

    New Technique of Exposed Glaucoma Drainage Tube Repair: Report of a Case
    • 2
    • PDF
    Grafts in Glaucoma Surgery: A Review of the Literature.
    • 10
    • PDF
    Patch graft using collagen matrix (Ologen) for glaucoma drainage device exposure in a patient with Boston Keratoprosthesis type 1
    • 1
    • Highly Influenced
    Tube Exposure Repair
    • 11
    • PDF

    References

    SHOWING 1-10 OF 19 REFERENCES
    A novel use of amniotic membrane in the management of tube exposure following glaucoma tube shunt surgery
    • 72
    Autologous patch graft in tube shunt surgery.
    • 25
    Late-onset bacteria endophthalmitis following glaucoma drainage implantation.
    • 10
    Aqueous shunt tube erosion.
    • 67
    • Highly Influential
    Control of filtering bleb structure through tissue bioengineering: An animal model.
    • 78
    • PDF
    Tissue bioengineering for surgical bleb defects: an animal study
    • 58
    Clinical experience with the Baerveldt glaucoma drainage implant.
    • 175
    Inhibition of conjunctival scarring and contraction by a porous collagen-glycosaminoglycan implant.
    • 125
    • PDF